Frontlight ResearchEarly access
WithdrawnPhase 1
Cardiac Perfusion and Metabolism With [11C] Acetate PET/CT is Associated With Hematopoietic System Activation in Acute Decompensated Heart Failure: An Imaging Sub-study
Key facts
- Who runs it
- University of Alabama at Birmingham
- Where
- Birmingham, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Phase
- Phase 1
- Started
- 31 Dec 2025
- Ended
- 31 Oct 2026
- Type of study
- Interventional
- Treatments tested
- Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT
- Record updated
- 7 April 2023
- Why it stopped
- The study was not able to enroll any eligible subjects.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- At least 18 years of age
- Enrollment in the UAB CMC-ADHF study under the separate UAB approved research protocol (IRB-300000114, PI Rajapreyar)
- Negative urine or serum β-hCG test within 48 hours of [11C] acetate administration in women of child bearing potential. Women who are post-menopausal with at least 1 year since last menses or documented surgical sterilization will not require pregnancy testing
Who cannot take part
- Inability to provide informed consent
- Pregnancy
- Inability to lie still for the imaging study
- Weight exceeding the weight limit of the PET imaging table (500 pounds)
Where in United States
- University of Alabama at Birmingham Medical CenterBirmingham, United States
About the trial
What the trial wants to find out
The purpose of this sub-study is to use positron emission tomography and computed tomography imaging (PET/CT) with an investigational drug called [11C] acetate to see if inflammation in patients with acute decompensated heart failure (ADHF) can cause changes in blood flow and oxygen use in the heart. This study may help physicians better understand how to treat patients diagnosed with ADHF in the future.
The group in the trial
- patients with acute decompensated systolic and diastolic heartTreatment being tested
Treatment: Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 7 April 2023